MAPK3 and pancreatic neoplasm: In human pancreatic cancer cells, inhibition of ERK1/2 activities caused downregulation of antiapoptotic proteins BCL-2, MCL-1, and BCL-Xl without affecting the proapoptotic proteins BAX and BAK [41].